INTRODUCTION {#S1}
============

As a central signaling transducer, Ca^2+^ is integral to basic neuronal processes including membrane excitability and neuro-transmitter release from the synapse. In the nucleus, Ca^2+^ activates kinases that phosphorylate and thus activate CREB ([@R19]), a major transcriptional regulator of cellular programs critical for neuronal survival, plasticity, learning, and memory ([@R6]).

The long-standing "calcium hypothesis of Alzheimer's disease" posits that Ca^2+^ dyshomeostasis is a major mediator of neuronal deterioration ([@R24]). Neuropatho-logically, Alzheimer's disease is defined by the presence of amyloid β plaques and neurofibrillary tau tangles in postmortem human brain samples ([@R9]). Although a significant decrease in CREB and pCREB levels has been reported in postmortem human Alzheimer's disease brain tissue ([@R5]; [@R7]; [@R35]), in primary hippocampal neurons from tau transgenic mice ([@R46]), and in β amyloid-based mouse models of Alzheimer's disease ([@R17]; [@R35]), no study to date has investigated nuclear Ca^2+^ in the context of Alzheimer's disease and related tauopathies despite the well-established connection between nuclear Ca^2+^ and CREB activation ([@R19]).

To study potential links between pathogenic forms of tau and nuclear Ca^2+^, we utilized a *Drosophila* model of tauopathy and induced pluripotent stem cell (iPSC)-derived neurons from patients with sporadic Alzheimer's disease. We selected a *Drosophila* model carrying a human tau transgene harboring the *R406W* disease-associated mutation ([@R44]). Tau^R406W^ is one of many mutations in the *microtubule-associated protein tau* (*MAPT*) gene that cause an autosomal dominant neurological disorder termed frontotemporal lobar degeneration (FTLD)-tau with *MAPT* mutation ([@R14]; [@R22]). In *Drosophila*, similar mechanisms of tau-induced toxicity are shared by transgenic expression of various disease-associated tau mutations, which model human FTLD-tau with *MAPT* mutation, and wild-type human tau, which models Alzheimer's disease-associated tauopathy and other primary tauopathies not attributable to *MAPT* mutation ([@R4]). The tau^R406W^ *Drosophila* model has been used widely to study tau biology due to its mild toxicity at day 10 of adulthood, which is convenient for genetic analyses and precedes exponential decline in survival. To determine if our findings in tau^R406W^ transgenic *Drosophila* were relevant to the wider group of human tauopathies that involve pathogenic forms of wild-type tau, we extended our studies to iPSC-derived neurons from patients with sporadic Alzheimer's disease.

We report that panneuronal expression of human tau^R406W^ in the adult *Drosophila* brain is sufficient to deplete nuclear CREB protein levels, suggesting that pathogenic forms of tau may contribute to the previously reported nuclear depletion of CREB/pCREB in neurons of post-mortem human Alzheimer's disease brains ([@R5]; [@R7]; [@R35]). We find that genes previously identified as CREB-regulated are over-represented among transcripts that are depleted in tau^R406W^ transgenic *Drosophila*, suggesting that tau-induced CREB reduction significantly affects the transcriptome. We look upstream of CREB to find that both resting levels of nuclear Ca^2+^ and KCl-induced influx of nuclear Ca^2+^ are reduced as a result of human tau^R406W^ expression in the adult *Drosophila* brain. We find that nuclear Ca^2+^ influx in response to membrane depolarization is also blunted in iPSC-derived neurons from patients with sporadic Alzheimer's disease, suggesting that our studies in *Drosophila* are relevant to sporadic human tauopathies that involve pathogenic forms of wild-type tau. Finally, our studies in *Drosophila* identify the BK channel as a pharmacologically targetable modifier of nuclear Ca^2+^ signaling and neuronal death in tauopathy. Taken together, our findings highlight a key role for nuclear Ca^2+^ and CREB depletion in the pathogenesis of Alzheimer's disease and related tauopathies.

RESULTS {#S2}
=======

Pathogenic Tau^R406W^ Induces Nuclear CREB Depletion in Neurons of the Adult *Drosophila* Brain {#S3}
-----------------------------------------------------------------------------------------------

Previous studies report that levels of total and nuclear CREB and pCREB are reduced in postmortem human Alzheimer's disease brains ([@R5]; [@R7]; [@R35]). To determine if pathogenic forms of tau can contribute to nuclear CREB depletion, we utilized a well-described *Drosophila* model of tauopathy ([@R44]). Transgenic expression of human tau^R406W^ in *Drosophila* neurons recapitulates many aspects of human Alzheimer's disease and related tauopathies including the degeneration of synapses ([@R30]), ectopic cell cycle activation ([@R25]), DNA damage ([@R15]; [@R26]), and progressive neuronal death ([@R25]; [@R44]).

To directly quantify the effects of pathological tau on the *Drosophila* homolog of human CREB, CrebB ([@R40]; [@R45]) (referred to throughout as "CREB" for simplicity), we performed western blotting on lysates from tau^R406W^ transgenic *Drosophila* heads at day 10 of adulthood, an age at which neurodegeneration is detectable, but prior to exponential decline in lifespan ([@R16]). Using an antibody that detects all CREB isoforms, we find that total CREB levels are depleted in heads of tau^R406W^ transgenic *Drosophila* versus controls ([Figure 1A](#F1){ref-type="fig"}). We next directly visualized CREB localization by co-staining control and tau^R406W^ *Drosophila* brains with antibodies detecting CREB and elav, a protein restricted to neuronal nuclei. Similar to previous reports in postmortem human brains with Alzheimer's disease ([@R5]; [@R7]; [@R35]), we find that total CREB ([Figure 1B](#F1){ref-type="fig"}) and nuclear CREB ([Figure 1C](#F1){ref-type="fig"}) are significantly depleted in brains of adult tau^R406W^ transgenic *Drosophila*.

CREB-Regulated Genes Are Over-Represented among Differentially Expressed Genes in Tau^R406W^ Transgenic *Drosophila* {#S4}
--------------------------------------------------------------------------------------------------------------------

As CREB is a transcription factor that is depleted in tau^R406W^ transgenic *Drosophila*, we next determined if CREB-regulated genes are over-represented among transcripts that are differentially expressed in brains of tau^R406W^ transgenic *Drosophila*. Genes that harbor a CREB-response element (CRE) between 3,000 bp upstream and 500 bp downstream of their transcription start site that have previously been identified as CREB targets based on chromatin immunoprecipitation sequencing (ChIP-seq) ([@R21]; [Data S1](#SD2){ref-type="supplementary-material"}) were considered "CREB-regulated." The antibody used for ChIP-seq recognizes both activating and repressive isoforms of *Drosophila* CREB ([@R21]). Genes that are differentially expressed between control and tau^R406W^ transgenic *Drosophila* at day 10 of adulthood were identified by RNA sequencing ([Data S2](#SD3){ref-type="supplementary-material"}). A hypergeometric test indicated that CREB-regulated genes are significantly over-represented among genes that are upregulated (1.84-fold enrichment, p = 3.77E--06) and downregulated (1.55-fold enrichment, p = 0.00046) in tau^R406W^ transgenic *Drosophila* compared to control ([Data S3](#SD4){ref-type="supplementary-material"}, gene list and Gene Ontology \[GO\] analysis). Although we cannot conclude that differential expression of these genes is a direct consequence of CREB depletion, this finding is consistent with the hypothesis that tau^R406W^-induced CREB depletion significantly affects the transcriptome.

Physiological Aging and Tau^R406W^ Cause a Toxic Depletion of Nuclear Ca^2+^ in the *Drosophila* Brain {#S5}
------------------------------------------------------------------------------------------------------

Given the dependence of CREB-mediated transcription on the presence of nuclear Ca^2+^ ([@R19]), we next determined the effect of pathological tau^R406W^ on nuclear Ca^2+^ using a GFP-based genetically encoded Ca^2+^ indicator fused to a nuclear localization signal, GCaMP3.NLS ([@R43]). Upon binding to Ca^2+^, genetically encoded Ca^2+^ indicators undergo a conformational change that induces fluorescence ([@R31]). We focused specifically on the cells of the mushroom body of the adult fly brain, as activation of the nuclear Ca^2+^ reporter can be visualized in this brain region in living flies ([@R43]; [Figure 2A](#F2){ref-type="fig"}), and the mushroom body is central to *Drosophila* learning and memory ([@R20]). *In vivo* confocal imaging reveals that tau^R406W^ transgenic *Drosophila* have significantly lower resting levels of nuclear Ca^2+^ in the cells of the mushroom body compared to controls at day 10 of adulthood ([Figure 2B](#F2){ref-type="fig"}). Importantly, we found that decreased nuclear Ca^2+^ levels are not simply a result of extensive neuronal loss ([Figure S1A](#SD1){ref-type="supplementary-material"}). As an important control, we confirmed that transgenic human tau^R406W^ does not affect expression levels of the genetically encoded Ca^2+^ indicator itself ([Figure S1B](#SD1){ref-type="supplementary-material"}).

To determine if tau^R406W^-induced nuclear Ca^2+^ depletion is age-dependent, we quantified resting levels of nuclear Ca^2+^ at day 1, 10, and 30 of adulthood in control and tau^R406W^ transgenic *Drosophila*. We extended our analysis to 60 days in control flies, which is close to their maximum lifespan of \~70 days, and exceeds the maximum lifespan of tau^R406W^ transgenic *Drosophila* of \~35 days ([@R16]). In both genotypes, we find a significant age-dependent decrease in levels of resting nuclear Ca^2+^ ([Figures S1C](#SD1){ref-type="supplementary-material"} and [S1D](#SD1){ref-type="supplementary-material"}). Although nuclear Ca^2+^ levels do not significantly differ between control and tau^R406W^ transgenic *Drosophila* at day 1 of adulthood, we find that tau^R406W^ transgenic *Drosophila* have reduced levels of nuclear Ca^2+^ compared to controls at days 10 and 30 ([Figure 2C](#F2){ref-type="fig"}), indicating that tau^R406W^ exacerbates the depletion of resting nuclear Ca^2+^ levels that occurs with normal aging.

To determine if depletion of nuclear Ca^2+^ signaling is causally associated with neurodegeneration, we overexpressed a recombinant blocker of nuclear Ca^2+^, CaMBP4 ([@R43]), in neurons of the adult *Drosophila* brain. CaMBP4 is a nuclear protein that contains four copies of a calmodulin-binding peptide (M13). CaMBP4 binds to and inactivates Ca^2+^-bound calmodulin complexes, thus blocking activation of Ca^2+^-dependent nuclear signaling cascades. Although blocking nuclear Ca^2+^-dependent processes via CaMBP4 overexpression is not sufficient to induce neuronal death at day 10 of adulthood based on terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), we find that genetically blocking nuclear Ca^2+^ signaling in tau^R406W^ transgenic *Drosophila* significantly enhances tau^R406W^-induced neuronal death ([Figure 2D](#F2){ref-type="fig"}). Taken together, these data suggest that tau^R406W^-induced decrease in nuclear Ca^2+^ signaling is causally associated with neurodegeneration.

Decreased Influx of Nuclear Ca^2+^ in Tau^R406W^ Transgenic *Drosophila* and iPSC-Derived Neurons from Sporadic Human Alzheimer's Disease Patients in Response to Membrane Depolarization {#S6}
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Ca^2+^ is a central regulator of communication between the synapse and nucleus, and Ca^2+^ that enters the nucleus in response to synaptic activity mediates memory formation ([@R3]). Having established that resting levels of nuclear Ca^2+^ are depleted as a consequence of pathogenic tau^R406W^, we next determined if influx of Ca^2+^ into the nucleus is affected in tauopathy when the membrane is induced to depolarize. We quantified nuclear Ca^2+^ upon *in vivo* brain exposure to 70 mM KCl, which induces membrane depolarization and opening of voltage-gated Ca^2+^ channels ([@R13]). After normalizing to resting nuclear Ca^2+^ levels, we find that KCl-induced nuclear Ca^2+^ influx is significantly depleted in brains of tau^R406W^ transgenic *Drosophila* at day 10 of adulthood compared to control ([Figures 3A](#F3){ref-type="fig"} and [3B](#F3){ref-type="fig"}). Together with our previous findings, these data indicate that both resting levels and membrane depolarization-induced nuclear Ca^2+^ influx are depleted as a consequence of pathogenic tau^R406W^.

We next utilized iPSC-derived neurons from patients with sporadic Alzheimer's disease to determine if our findings were relevant to a human tauopathy that involves pathogenic forms of wild-type tau. As in brains of patients with Alzheimer's disease, iPSC-derived neurons from patients with Alzheimer's disease are reported to feature disease-associated tau phosphorylation ([@R23]; [@R32]). After differentiating iPSCs into excitatory forebrain neurons ([@R11]; [@R36]; [@R37]), we quantified membrane depolarization-induced changes in nuclear Ca^2+^ levels using a GCaMP6s.NLS genetically encoded nuclear Ca^2+^ sensor ([@R18]). We do not observe differences in differentiation status between iPSC-derived neurons from control and Alzheimer's disease patients ([Figure S2](#SD1){ref-type="supplementary-material"}). We find that KCl-induced increase of nucleoplasmic Ca^2+^ is reduced in iPSC-derived neurons from three different sporadic cases of human Alzheimer's disease versus controls ([Figures 3C](#F3){ref-type="fig"} and [3D](#F3){ref-type="fig"}), suggesting that the blunting of KCl-induced nuclear Ca^2+^ influx detected in tau^R406W^ transgenic *Drosophila* is relevant to human Alzheimer's disease and is not restricted to the *R406W* tau mutation.

Manipulation of BK Channels Modifies Tau^R406W^-Induced Nuclear Ca^2+^ Reduction and Neurotoxicity {#S7}
--------------------------------------------------------------------------------------------------

We became interested in BK channels as a potential mechanistic link between pathogenic tau and nuclear Ca^2+^ depletion based on a previous study reporting that BK channels regulate induced release of Ca^2+^ from nuclear envelope stores ([@R27]). We find that oral administration of a potent activator of BK channels, BMS-191011, significantly increases resting levels of nuclear Ca^2+^ in cells of the mushroom body of the adult tau^R406W^ transgenic *Drosophila* brain ([Figures 4A](#F4){ref-type="fig"} and [4B](#F4){ref-type="fig"}). In addition, we find that BMS-191011 significantly reduces neurodegeneration in tau^R406W^ transgenic *Drosophila* at day 10 of adulthood ([Figure 4C](#F4){ref-type="fig"}).

Having established that manipulation of BK channels is sufficient to increase nuclear Ca^2+^ and suppress neurodegeneration in tau^R406W^ transgenic *Drosophila*, we next determined if genetic depletion of the *Drosophila* BK channel homolog, *slowpoke*, enhances tau^R406W^-induced neurodegeneration. We decreased slowpoke activity by RNAi-mediated reduction (*slo*^*RNAi*^) or introduction of a heterozygous loss-of-function mutation (*slo*^*1*^). Although neither genetic manipulation is sufficient to induce neuronal death based on TUNEL staining at day 10 of adulthood, we find that both *slo*^*RNAi*^ and *slo*^*1*^ significantly enhance tau^R406W^-induced neuronal death ([Figure 4D](#F4){ref-type="fig"}). Taken together, these data suggest that manipulation of BK channels can modify tau^R406W^-induced nuclear Ca^2+^ reduction and consequent neuronal death.

DISCUSSION {#S8}
==========

In the current study, we investigate the effects of pathogenic tau on nuclear Ca^2+^ and CREB. Our studies suggest that pathogenic tau directly contributes to CREB depletion, as we find that panneuronal expression of human transgenic tau^R406W^ in the adult *Drosophila* brain is sufficient to reduce total and nuclear levels of CREB protein. Based on RNA sequencing, we detect a significant over-representation of CREB-regulated genes among transcripts that are differentially expressed in tau^R406W^ transgenic *Drosophila* compared to control. As differential splicing produces both activating and repressive CREB isoforms in *Drosophila* ([@R45]), the overrepresentation of CREB-regulated genes that are both up- and downregulated in tau^R406W^ transgenic *Drosophila* is not unexpected. Although these data are consistent with the role of CREB as a key cellular transcription factor, additional studies are required to determine if the transcriptional changes in tau^R406W^ transgenic *Drosophila* are a direct result of CREB depletion.

Based on the dependence of CREB activation on nuclear Ca^2+^, we then visualized nuclear Ca^2+^ levels in neurons of live *Drosophila* brains using a genetically encoded, nuclear-localized Ca^2+^ indicator. The ability to quantify nuclear Ca^2+^ levels as a function of biological aging is an advantage of the *Drosophila* system. We found that resting-state nuclear Ca^2+^ levels are depleted with physiological aging, and that pathogenic tau^R406W^ significantly exacerbates age-associated nuclear Ca^2+^ depletion. We found that genetic blockage of nuclear Ca^2+^ signaling further enhances tau^R406W^-induced neuronal death, suggesting that nuclear Ca^2+^ depletion is a causal mediator of neurodegeneration in tauopathy.

As generation of nuclear Ca^2+^ transients are a key route of communication between synapses and nuclei, we next asked if KCl-induced nuclear Ca^2+^ influx is depleted in the context of tauopathy. Using tau^R406W^ transgenic *Drosophila* as well as iPSC-derived neurons from patients with sporadic Alzheimer's disease, we find that the nuclear Ca^2+^ response to KCl-induced depolarization is blunted in both model systems. Our studies in tau^R406W^ transgenic *Drosophila* and in human Alzheimer's disease iPSC-derived neurons suggest that depletion of nuclear Ca^2+^ is neither specific to the *Drosophila* system nor *R406W* mutant tau.

We identify BK channels as a potential pharmacologically targetable link between pathogenic tau and nuclear Ca^2+^ depletion. Treatment of tau^R406W^ transgenic *Drosophila* with a BK channel activator increases nuclear Ca^2+^ levels and suppresses tau^R406W^ neurotoxicity, while genetically depleting BK channels significantly enhances tau^R406W^ neurotoxicity. A previous study has reported that BK channels are present in the nuclear envelope and regulate nuclear Ca^2+^ levels, nuclear Ca^2+^ signaling, and activity-evoked gene expression ([@R27]). While we cannot rule out the possibility that BK channels on the plasma membrane contribute to nuclear Ca^2+^ regulation in neurons of tau^R406W^ transgenic *Drosophila*, we would expect that activation of BK channels on the plasma membrane would hyperpolarize the membrane, preventing further Ca^2+^ influx into the cytoplasm. We thus speculate that nuclear envelope-localized BK channels, rather than plasma membrane-localized BK channels, are the primary contributor to nuclear Ca^2+^ depletion in tauopathy by influencing Ca^2+^ stores in the nuclear envelope.

Pharmacological blockade of nuclear BK channels was previously reported to elevate nuclear Ca^2+^ in isolated neuronal nuclei and in cultured mouse hippocampal neurons ([@R27]), which conflicts with our finding that that activation of BK channels elevates nuclear Ca^2+^ in brains of tau^R406W^ transgenic *Drosophila*. Several differences between our respective experimental designs may underlie the discrepancy between studies. First, [@R27] analyzed nuclear Ca^2+^ in isolated nuclei and cultured neurons, whereas our live-imaging measurements of nuclear Ca^2+^ utilize intact *Drosophila* brains. Second, we analyzed levels of resting nuclear Ca^2+^ in tau^R406W^ transgenic *Drosophila* in response to chronic exposure to the BK channel activator throughout adulthood, whereas [@R27] measured nuclear Ca^2+^ influx in response to transient BK channel blockage. Despite divergent findings between the two studies, both point toward a critical role of BK channels as a regulator of nuclear Ca^2+^. Our study is consistent with that of [@R41], [@R42]), who find that drug-induced BK channel activation suppresses cognitive deficits in the 3xTg mouse model of Alzheimer's disease, which harbors *APP*, *PS1*, and *MAPT* disease-associated mutant human transgenes ([@R33]).

Why might depletion of nuclear Ca^2+^ be toxic to neurons? In addition to regulating a neuroprotective genetic program consisting of synaptic activity-induced "activity-regulated inhibitor of death" genes ([@R47]), nuclear Ca^2+^ has been identified as a key regulator of the autolysosomal system ([@R36]). As the autophagy-lysosome system is clearly dysfunctional in tauopathy ([@R39]), determining the effects of tau-induced nuclear Ca^2+^ depletion on protein clearance pathways is an important avenue of investigation for future studies.

In summary, our study provides insight into the effects of pathogenic tau on nuclear Ca^2+^, which is a major mediator of communication between synapses and nuclei ([@R3]) and regulator of protein clearance pathways ([@R36]). We identify nuclear Ca^2+^ depletion as a pathomechanism connecting disease-associated forms of tau to neuronal death, adding an important dimension to the long-standing Ca^2+^ hypothesis of Alzheimer's disease.

STAR⋆ METHODS {#S9}
=============

RESOURCE AVAILABILITY {#S10}
---------------------

### Lead Contact {#S11}

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Dr. Bess Frost (<bfrost@uthscsa.edu>).

### Materials Availability {#S12}

This study did not generate new unique reagents.

### Data and Code Availability {#S13}

The accession number of the raw RNA-seq files for *Drosophila* control versus tau^R406W^ transgenic *Drosophila* reported in this paper is GEO: GSE152278.

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S14}
--------------------------------------

### *Drosophila* genetics and models {#S15}

All *Drosophila melanogaster* crosses and aging were performed at 25°C on a 12-hour light/dark cycle. Males and females of indicated genotypes were housed in the same vial, and each experiment utilized an equal number of male and female flies. Food was made fresh weekly and flies were transferred to fresh food every two days. Transgenic flies harboring human tau^R406W^ have been described previously ([@R44]). Panneuronal expression of transgenes or RNAi small hairpins were achieved using the Gal4/UAS system with the *elav* promoter driving expression of the Gal4 transcription factor. UAS-slo^RNAi^ and slo^1^ were obtained from the Bloomington *Drosophila* Stock Center. UAS-GCaMP3.NLS and CaMBP4 transgenic flies were generously provided by Dr. Hilmar Bading ([@R43]).

### iPSC-derived neurons {#S16}

iPSCs from sporadic Alzheimer's disease patients (no *ApoE4* carriers) and control lines were obtained from the Coriell Institute (Camden, NJ). Neural progenitor cells were derived following established protocols ([@R11]) and differentiated into forebrain neurons by stepwise addition (daily half-feeds for one week) of neurodifferentiation media composed of Neurobasal Medium supplemented with B-27 minus retinoic acid, Glutamax and Pen/Strep as described ([@R36]; [@R37]). The resulting excitatory forebrain neurons are cultured for another three weeks to allow further differentiation, which is monitored by expression of neuronal markers including MAP2 and vGluT1 ([Figure S2](#SD1){ref-type="supplementary-material"}).

METHOD DETAILS {#S17}
--------------

### RNA sequencing and analysis {#S18}

6 biologically independent replicates were sequenced per genotype, each consisting of 15--30 ng of total RNA from 18 pooled *Drosophila* heads (108 heads per genotype in total). Trizol-extracted RNA was used for library preparation using the Ovation RNA-Seq System for *Drosophila* according to the User Guide. After quantification by Qubit and bioanalysis, libraries were pooled, purified by magnetic bead extraction and sequenced on the Illumina HiSeq 3000 platform with 100 base pair paired-end sequencing. Library quality control and RNA-sequencing was performed by the Genome Sequencing Facility at Greehey Children's Cancer Research Institute at the University of Texas Health San Antonio.

Raw FASTQ files underwent quality control and were trimmed with Trimmomatic v.0.36 ([@R8]) to remove adapters and low-quality reads. FastQC (<http://www.bioinformatics.babraham.ac.uk/projects/fastqc/>) was used to evaluate the quality of the reads before and after trimming. Trimmed FASTQ files were mapped and aligned to the *Drosophila melanogaster* transcriptome (FlyBase ([@R38]) FB2018_6.27) using Salmon v.0.13.1 ([@R34]). Differential expression analysis was performed using DESeq2 v1.24 ([@R28]). Genes with an adjusted p value of less than 0.05 were considered significant.

### CRE and CREB binding-site analyses {#S19}

Genes harboring a CRE were identified through the FindM program ([@R1]; [@R10]). The canonical full CRE site and the CRE half site were included. One mismatch was allowed for full sites, and no mismatches were allowed for half sites. CRE prediction sites that were between 3,000 bp upstream and 500 bp downstream of annotated genomic transcription start sites were utilized in subsequent analyses.

To validate predicted CREB target sites, CREB ChIP-seq data were downloaded from the Gene Expression Omnibus (GEO: GSE73386, samples GSM1892406 and GSM1892408) ([@R12]; [@R21]) and compared to predicted CRE sites. Files were converted into GRanges format and annotated with ChIPpeakAnno ([@R48]). CREB ChIP-seq peaks that did not fall between 3,000 bp upstream and 500 bp downstream of an annotated TSS were discarded. The intersection between FindM-based CRE-containing genes, ChIP-seq-based CREB-bound genes, and genes that were up and downregulated in tau^R406W^ transgenic *Drosophila* compared to control (adjusted p \< 0.05) were extracted. A hypergeometric test was used to determine enrichment of CRE-containing, CREB-regulated genes in the lists of up and downregulated genes. GO analysis was performed on the CRE-containing, CREB-regulated genes that were up and downregulated in tau^R406W^ transgenic *Drosophila* using the GO Enrichment Analysis tool ([@R2]), which utilizes the *Drosophila melanogaster* genome as a background gene set ([Data S3](#SD4){ref-type="supplementary-material"}). GO annotations with a false discovery rate (FDR) of less than 0.05 were considered significant.

### Ca^2+^ imaging {#S20}

To quantify resting nuclear Ca^2+^ levels in brains of living flies ([Figures 2A](#F2){ref-type="fig"}--[2C](#F2){ref-type="fig"}, [4A](#F4){ref-type="fig"}, and [4B](#F4){ref-type="fig"}), a single fly was placed on a CO~2~ gas pad until the fly lost postural control, then transferred into a 100% ethanol bath for 10 s. Using a small Sylgard dissection surface, the fly was then placed in cold HL3 solution (70 mM NaCl, 5 mM KCl, 10 mM NaHCO~3~, 5 mM trehalose, 115 mM sucrose, 5 mM HEPES, 0.5 mM CaCl~2~, 3 mM MgCl~2~) and pinned using modified minutien pins on its ventral surface ([@R29]). Once positioned, a small piece of cuticle was removed from the posterior side of the head (cuticular window) to reveal the underlying mushroom body ([@R43]). GFP fluorescence resulting from GCaMP3.NLS activation was imaged with a Zeiss LSM 780 NLO with Examiner. ImageJ was used for analysis. Six biological replicates were analyzed per group.

To quantify the nuclear Ca^2+^ response to KCl-induced membrane depolarization ([Figures 3A](#F3){ref-type="fig"} and [3B](#F3){ref-type="fig"}), flies were first prepared for imaging in a cold HL3 solution as described above, and resting GCaMP3.NLS fluorescence levels were recorded. HL3 was removed from the exposed fly brain by pipetting and was immediately replaced with a modified HL3 solution containing 70 mM KCl. GCaMP3.NLS reporter intensity stabilizes a few seconds after KCl exposure, as flies experience some movement within the imaging system as a result of the physical administration of the buffer. After a three second recovery, baseline intensity was set to one for both control and tau^R406W^ transgenic *Drosophila*. The KCl-induced nuclear Ca^2+^ response is presented as change from baseline ([@R43]). Six biological replicates were analyzed per group.

In iPSC-derived neurons, nuclear Ca^2+^ levels were measured using the human *Synapsin 1* promoter-driven GCaMP6s.NLS ([@R18]), ensuring expression exclusively in neurons. This genetically encoded nuclear Ca^2+^ reporter was transfected into iPSC-derived human neurons using BioT. To assess transfection efficiency and simplify visualization of transfected cells during the experiment, cells were co-transfected with membrane-RFP (mRFP) in addition to GCaMP6s.NLS. While mRFP labels all transfected cells, GCaMP6s.NLS fluorescence is restricted to neurons and is induced following KCl-mediated depolarization. mTagRFP-Membrane-1 was a gift from Michael Davidson (Addgene plasmid \#57992).

Baseline fluorescence and KCl (25 mM)-induced GCaMP6s.NLS fluorescence were measured by spinning disc confocal microscopy over time, and peak fluorescence intensities were recorded. Minima and maxima intensities were normalized to 0 or 1, respectively. Data are presented as peak ΔF/F~0~, in which ΔF is the change in fluorescence and F~0~ is baseline fluorescence. Cells with saturating F~0~ fluorescence are excluded from experimental measurements. To avoid measuring nuclear Ca^2+^ in cells that have no or very low expression of the GCaMP6s.NLS nuclear Ca^2+^ indicator, the microscopy field of view is set such that all cells within the field of view exhibit a baseline GFP signal. ΔF/F~0~ peak values presented in [Figure 3D](#F3){ref-type="fig"} represent the maximum values of longitudinal measurements (ΔF/F~0~ over time). Longitudinal measurements did not plateau at their maxima at any point in time, indicating that the signal was not saturated. A technical replicate consists of the average signal from at least 50 single cells derived from one patient sample. There were six technical replicates assayed per patient-derived sample, with two biologically distinct control samples and three biologically distinct sporadic Alzheimer's disease samples.

### Drug Preparation {#S21}

BMS 191011 was prepared as a stock solution in ethanol and diluted in fly food to a final concentration of 20 μM. Vehicle-treated flies were reared on food containing an equivalent volume of ethanol. Flies were treated from day 2--10 of adulthood.

### Western blotting {#S22}

Frozen *Drosophila* heads were homogenized in 20 μL 2X Laemmli sample buffer, boiled for 10 min, and run on a 4%--20% SDS-PAGE gel. Equal loading of protein was assessed by Ponceau S staining prior to blotting. After blocking membranes in PBS plus 0.05% Tween (PBS~TW~) and 2% milk, membranes were incubated with primary antibodies overnight at 4°C. After washing in PBS~TW~, membranes were incubated with their respective HRP-conjugated secondary antibodies for 2 hr at room temperature. Blots were developed with Clarity Max ECL Western Blotting Substrate. Band intensity was quantified with ImageJ. Antibodies against actin and GFP were used at 1:10,000 for western blotting, and CREB was used at 1:500.

### Immunofluorescence and histology {#S23}

For *Drosophila* studies, *Drosophila* brains were dissected in PBS and fixed in methanol for 20 min. After blocking with 2% milk PBS~Tr~ for 30 minutes, brains were incubated with primary antibody diluted in blocking solution overnight at 4°C. After washing with PBS~Tr~, brains were incubated with Alexa488- or Alexa555-conjugated secondary antibodies for 2 hr at room temperature in 2% milk dissolved in PBS~T~. Slides were washed with PBS~Tr~ and then incubated with DAPI for 2 minutes to visualize nuclei. Brains were imaged by confocal microscopy (Zeiss LSM 780 NLO with Examiner). ImageJ was used for analysis. For quantification of neuronal nuclear CREB in *Drosophila*, dissected brains were fixed in 100% methanol and stained with antibodies detecting *Drosophila* CREB and elav (1:100 and 1:5, respectively). Elav-based masks were created in ImageJ and CREB fluorescence within the elav-positive area was quantified in six control and six tau^R406W^ transgenic dissected *Drosophila* brains.

TUNEL staining was performed on 4 μm sections of formalin-fixed, paraffin embedded *Drosophila* heads. Secondary identification of TUNEL-positive nuclei was performed using DAB. TUNEL-positive nuclei were counted throughout the entire brain by bright field microscopy.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S24}
---------------------------------------

A Student's t test was used for all pairwise comparisons. A one-way ANOVA using a Tukey multiple comparisons test (alpha = 0.05) was used to compare all multiple values. For all statistical analyses, a confidence interval of 95% and normal distribution were assumed. For *in vivo Drosophila* experiments ([Figures 1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}, [3A](#F3){ref-type="fig"}, [3B](#F3){ref-type="fig"}, and [4](#F4){ref-type="fig"}), each biological replicate is one *Drosophila* brain. For *in vitro* iPSC-derived neuron experiments ([Figures 4C](#F4){ref-type="fig"} and [D](#F4){ref-type="fig"}), each biological replicate is one biologically distinct patient-derived cell population. Statistical analysis was performed using Prism8. Statistical details can be found in the figure legends and text, where appropriate.

Supplementary Material {#SM1}
======================

We thank Dr. Hilmar Bading for providing GCaMP3.NLS and UAS-CaMBP4 *Drosophila* lines and GCaMP6s.NLS constructs and Peter Ngam (NuGen/Tecan) for training in use of the Ovation RNA-Seq system. The UT Health San Antonio Genome Sequencing Facility is supported by UT Health San Antonio, NIH-NCI P30 CA054174 (Cancer Center at UT Health San Antonio), NIH Shared Instrument grant 1S10OD021805 (S10 grant), and CPRIT Core Facility Award (RP160732). The Actin and GFP antibodies were obtained from the Developmental Studies Hybridoma Bank, created by the NICHD of the NIH and maintained at The University of Iowa, Department of Biology, Iowa City, IA 52242. The graphical abstract was created using Adobe Illustrator and Bio-render ([https://www.biorender.com](https://www.biorender.com/)). This study was supported by the American Federation for Aging Research New Investigator in Alzheimer's Disease (B.F.) and the National Institute on Aging (R01 AG062475 to R.D. and B.F.). R.M. was supported by an NIGMS-funded K12 GM111726.
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![Tau^R406W^ Causes Reduction of Nuclear CREB in Neurons of the Adult *Drosophila* Brain\
(A) CREB protein levels in control and tau^R406W^ transgenic *Drosophila* head lysates based on western blotting, n = 6 biological replicates.\
(B) CREB and elav immunostaining in the mushroom body of control and tau^R406W^ transgenic *Drosophila* visualized by confocal microscopy. Images are from a single focal plane. n = 5 biological replicates. Scale bar, 5 μm.\
(C) CREB and elav immunostaining in the mushroom body of control and tau^R406W^ transgenic *Drosophila* visualized by confocal microscopy. Images are from a single focal plane. Elav-based masks (represented by white outlines) were used to measure nuclear CREB levels, n = 5 biological replicates. Scale bar, 5 mm.\
All assays were performed at day 10 of adulthood. Data are presented as mean ± SEM; unpaired t test; \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001.](nihms-1612497-f0002){#F1}

![Tau^R406W^ Transgenic *Drosophila* Have a Toxic Reduction of Nuclear Ca^2+^\
(A) Activation of the nuclear Ca^2+^ reporter in the mushroom body of the adult *Drosophila* brain based on GCaMP3.NLS *in vivo* imaging.\
(B) Decreased levels of nuclear Ca^2+^ in the mushroom body of the tau^R406W^ transgenic *Drosophila* brain versus control based on GCaMP3.NLS *in vivo* imaging. Images are of a single focal plane. Scale bar, 60 μm\
(C) Quantification of nuclear Ca^2+^ based on GCaMP3.NLS in control and tau^R406W^ transgenic *Drosophila* of the indicated age. n = 6--8 biological replicates per genotype, per age. Data are presented as mean ± SD. For visual simplicity, significance is only noted for differences between genotypes at each age. Statistical analyses of the age-dependent decline in nuclear Ca^2+^ within each genotype are presented in [Figures S1C](#SD1){ref-type="supplementary-material"} and [S1D](#SD1){ref-type="supplementary-material"}.\
(D) Neurodegeneration assayed by TUNEL staining in brains of control and tau^R406W^ transgenic *Drosophila* with and without nuclear Ca^2+^ blockage via panneuronal overexpression of CaMBP4.\
All assays were performed at day 10 of adulthood with the exception of (C). Data are presented as mean ± SEM unless otherwise noted. One-way ANOVA with Tukey's multiple comparison test; \*\*\*p \< 0.001, \*\*\*\*p \< 0.0001.](nihms-1612497-f0003){#F2}

![KCl-Induced Nuclear Ca^2+^ Influx Is Reduced in Brains of Tau^R406W^ Transgenic *Drosophila* and in iPSC-Derived Neurons from Sporadic Cases of Human Alzheimer's Disease\
(A) Decreased depolarization-dependent influx of nuclear Ca^2+^ in tau^R406W^ transgenic *Drosophila* compared to control in response to administration of 70 mM KCl through a cuticular window in heads of living *Drosophila*.\
(B) Quantification of the area under the curve from (A), n = 6 biological replicates.\
(C) Decreased KCl-induced release of nuclear Ca^2+^ in iPSC-derived neurons from patients with Alzheimer's disease. Cells were transfected with membrane-bound RFP and the GCaMP6s.NLS nuclear Ca^2+^ reporter. Images show peak nuclear Ca^2+^ levels induced by 25 mM KCl. Images are from a single focal plane. Scale bar, 10 μm.\
(D) Quantification of (C). Data are presented as peak ΔF/F~0~, in which ΔF is the change in GCaMP6s.NLS GFP fluorescence, and F~0~ is baseline GFP fluorescence. Nuclear Ca^2+^ was quantified in at least 50 single cells for each of six technical replicates per human sample. iPSC-derived neurons are from two control and three sporadic Alzheimer's disease patients.\
All assays in *Drosophila* were performed at day 10 of adulthood. Data are presented as the mean ± SEM; unpaired t test or ANOVA; \*\*p \< 0.01, \*\*\*p \< 0.001.](nihms-1612497-f0004){#F3}

![BK Channels Modify Nuclear Ca^2+^ Release and Neurotoxicity in Tau^R406W^ Transgenic *Drosophila*\
(A) Visualization of nuclear Ca^2+^ based on *in vivo* imaging of GCaMP3.NLS in tau^R406W^ transgenic *Drosophila* fed either vehicle or BMS-191011 from days 2--10 of adulthood. Images are from a single focal plane. Scale bar, 10 μm.\
(B) Quantification of (A), n = 6 biological replicates.\
(C) Neurodegeneration assayed by TUNEL staining in the brains of control and tau^R406W^ transgenic *Drosophila* with and without exposure to BMS-191011 from days 2--10 of adulthood, n = 6 biological replicates.\
(D) Neurodegeneration assayed by TUNEL staining in the brains of control and tau^R406W^ transgenic *Drosophila* with and without RNAi-mediated depletion or loss-of-function of *slowpoke*; n = 6 biological replicates.\
All assays were performed at day 10 of adulthood. Data are presented as mean ± SEM; unpaired t test or ANOVA; \*p \< 0.05, \*\*\*\*p \< 0.0001.](nihms-1612497-f0005){#F4}

###### 

KEY RESOURCES TABLE

  REAGENT or RESOURCE Antibodies                             SOURCE                                                                                                                                                                                IDENTIFIER
  ---------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------
  Antobodies                                                                                                                                                                                                                                       
  CREB                                                       Cell Signaling                                                                                                                                                                        9197; RRID: AB_331277
  Actin                                                      Developmental Studies Hybridoma Bank                                                                                                                                                  JLA20; RRID: AB_528068
  Elav                                                       Developmental Studies Hybridoma Bank                                                                                                                                                  9F8A9; RRID: AB_528217
  GFP                                                        Thermo Fisher Scientific                                                                                                                                                              CAB4211; RRID: AB_10709851
  MAP2                                                       Abcam                                                                                                                                                                                 5392; RRID: AB_2138153
  vGluT1                                                     Abcam                                                                                                                                                                                 Ab77822; RRID: AB_2187677
  Chemicals, Peptides, and Recombinant Proteins                                                                                                                                                                                                    
  BMS 191011                                                 N/A                                                                                                                                                                                   SML0866
  Critical Commercial Assays                                                                                                                                                                                                                       
  TUNEL - FragEL DNA Fragmentation Detection Kit             EMD Millipore                                                                                                                                                                         QIA33
  Ovation RNA-seq System for Drosophila                      NuGen                                                                                                                                                                                 0350
  Clarity Max ECL Western Blotting Substrate                 Bio-Rad                                                                                                                                                                               1705062
  Deposited Data                                                                                                                                                                                                                                   
  Control and tau^R406W^ RNA-seq data, day 10 of adulthood   GEO                                                                                                                                                                                   GEO: GSE152278
  Experimental Models: Cell Lines                                                                                                                                                                                                                  
  Control 1                                                  Coriell Institute                                                                                                                                                                     GM25430; RRID: CVCL_1 N86
  Control 2                                                  Coriell Institute                                                                                                                                                                     GM27717
  Alzheimer's Disease 1                                      Coriell Institute                                                                                                                                                                     CW50130; RRID: CVCL_JI63
  Alzheimer's Disease 2                                      Coriell Institute                                                                                                                                                                     CW50136; RRID: CVCL_ER61
  Alzheimer's Disease 3                                      Coriell Institute                                                                                                                                                                     CW50131; RRID: CVCL_HI88
  Experimental Models: Organisms/Strains                                                                                                                                                                                                           
  Elav-GAL4                                                  Bloomington Drosophila Stock Center                                                                                                                                                   458; RRID: BDSC_458
  w1118                                                      Bloomington Drosophila Stock Center                                                                                                                                                   3605; RRID: BDSC_3605
  UAS-tau^R406W^                                             Dr. Mel Feany                                                                                                                                                                         [@R44]
  UAS-GCaMP3.NLS                                             Dr. Hilmar Bading                                                                                                                                                                     [@R43]
  UAS-CaMBP4                                                 Dr. Hilmar Bading                                                                                                                                                                     [@R43]
  Slo^RNAi^                                                  Bloomington Drosophila Stock Center                                                                                                                                                   55405; RRID: BDSC_55405
  Slo^1^                                                     Bloomington Drosophila Stock Center                                                                                                                                                   4587; RRID: BDSC_4587
  Software and Algorithms                                                                                                                                                                                                                          
  Trimmomatic                                                [@R8]                                                                                                                                                                                 v.0.36; RRID: SCR_011848
  FastQC                                                     [http://www.bioinformatics.babraham.](http://www.bioinformatics.babraham.ac.uk/projects/fastqc/)[ac.uk/projects/fastqc/](http://www.bioinformatics.babraham.ac.uk/projects/fastqc/)   RRID: SCR_014583
  Salmon                                                     [@R34]                                                                                                                                                                                v.0.13.1
  DESeq2                                                     [@R28]                                                                                                                                                                                v1.24; RRID: SCR_015687
  FlyBase - *Drosophila* transcriptome                       [@R38]                                                                                                                                                                                FB2018_6.27; RRID: SCR_006549
  FindM                                                      [@R1]                                                                                                                                                                                 N/A
  Gene Expression Omnibus                                    [@R12]                                                                                                                                                                                N/A; RRID: SCR_005012
  ChlPpeakAnno                                               [@R48]                                                                                                                                                                                N/A; RRID: SCR_012828
  GraphPad Prism                                             GraphPad Software                                                                                                                                                                     Prism8; RRID: SCR_002798
  Other                                                                                                                                                                                                                                            
  CREB ChlP-seq dataset                                      [@R21]                                                                                                                                                                                GEO: GSE73386, samples GSM1892406 and GSM1892408
  Membrane-RFP plasmid                                       Addgene                                                                                                                                                                               57992; RRID: Addgene_57992
  GCaMP6s.NLS plasmid                                        Dr. Hilmar Bading                                                                                                                                                                     [@R18]
  BioT transfection reagent                                  Bioland Scientific                                                                                                                                                                    B01--01

###### Highlights

-   Tau^R406W^ induces nuclear CREB depletion in neurons of the adult *Drosophila* brain

-   Nuclear Ca^2+^ decreases with aging and tauopathy in the adult *Drosophila* brain

-   Nuclear Ca^2+^ is depleted in iPSC-derived neurons from sporadic Alzheimer's disease

-   Pharmacologic/genetic manipulation of BK channels modify tau^R406W^ neurotoxicity
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